Hirofumi Sumi
St. Marianna University School Of Medicine, 2-16-1, Sugao, Miyamae Ku
Kawasaki, 2168511, Japan
Kawasaki, 2168511, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Increased Skeletal Parathyroid Hormone Responsiveness and Risk of Decreased Lumbar Bone Mineral Density in Patients Receiving Chronic Hemodialysis: A 5-Year, Retrospective, Longitudinal Study.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
Published: March 03, 2026
Invasive Pneumococcal Disease Presenting with Pyogenic Spondylitis in a Patient on Chronic Hemodialysis Who Previously Received a Pneumococcal Vaccine: A Case Report.
Journal: Internal medicine (Tokyo, Japan)
Published: February 11, 2026
Letter to the Editor From Sumi and Tominaga: "Tolvaptan Versus Fluid Restriction in Moderate-Profound Hyponatremia: An Open-Label Randomized Clinical Trial".
Journal: The Journal of clinical endocrinology and metabolism
Published: August 26, 2025
Pathophysiology, symptoms, outcomes, and evaluation of hyponatremia: comprehension and best clinical practice.
Journal: Clinical and experimental nephrology
Published: July 08, 2024
Treatment of hyponatremia: comprehension and best clinical practice.
Journal: Clinical and experimental nephrology
Published: July 08, 2024
Potential influence of dietary guidance for advanced chronic kidney disease: comment on "Prevalence of hyponatremia and associated factors in patients with chronic kidney disease: the Fukuoka Kidney Disease Registry (FKR) study".
Journal: Clinical and experimental nephrology
Published: September 19, 2023
Effect of denosumab on bone mineral density in a postmenopausal osteoporotic woman with prolonged chronic mild hyponatremia.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Published: August 17, 2023
Comment on One-Year Romosozumab Treatment Followed by One-Year Denosumab Treatment for Osteoporosis in Patients on Hemodialysis: An Observational Study.
Journal: Calcified tissue international
Published: March 08, 2023
Letter to the Editor From Sumi et al.: "Lower Bone Turnover and Skeletal PTH Responsiveness in Japanese Compared to European Patients Receiving Hemodialysis".
Journal: The Journal of clinical endocrinology and metabolism
Published: October 27, 2022
Last Updated: 09/26/2026